| abstract |
The invention provides methods and compositions for treating hyperlipidemia and disorders associated with hyperlipidemia in a mammal. Compositions useful in the practice of the invention include a microsomal triglyceride transport protein inhibitor ('MTPI') and at least two other cholesterol lowering drugs selected from the group consisting of a cholesterol absorption inhibitor ('CAI'), a HMG-CoA reductase inhibitor, a bile acid sequestrant, a fibric acid derivative, niacin, and squalene sythetase inhibitor. |